Related Experiment Videos
Epidural scopolamine administration in preventing nausea after epidural morphine
R Moscovici1, G Prego, M Schwartz
1Department of Anesthesiology, Emek Medical Center, Afula, Israel.
Journal of Clinical Anesthesia
|September 1, 1995
Summary
Adding epidural scopolamine to epidural morphine significantly reduces postoperative nausea and vomiting. This combination therapy offers effective nausea and vomiting prevention without compromising pain relief after surgery.
Area of Science:
- Anesthesiology
- Pharmacology
- Surgical Care
Background:
- Postoperative nausea and vomiting (PONV) are common complications after surgery.
- Epidural morphine is frequently used for postoperative analgesia.
- Preventing PONV is crucial for patient recovery and satisfaction.
Purpose of the Study:
- To evaluate the efficacy of epidural scopolamine as an adjunct to epidural morphine for PONV prevention.
- To assess the impact of epidural scopolamine on postoperative pain management.
Main Methods:
- A randomized, double-blind study was conducted with 50 patients undergoing major abdominal and lower limb surgery.
- Participants received either epidural morphine alone or epidural morphine with scopolamine.
- Nausea and vomiting incidence were monitored during the first postoperative day.
Main Results:
- The group receiving epidural morphine plus scopolamine showed a significantly lower incidence of nausea and vomiting.
- No significant difference in the adequacy of analgesia was observed between the groups.
- Epidural scopolamine proved effective in reducing PONV.
Conclusions:
- Epidural scopolamine is an effective adjunct to epidural morphine for preventing postoperative nausea and vomiting.
- This combination therapy improves patient outcomes by reducing PONV incidence.
- The findings support the use of epidural scopolamine in multimodal PONV prophylaxis.